Britain's biggest drugmaker GlaxoSmithKline said on Thursday it had filed for European approval of its new once-weekly diabetes drug albiglutide, as tries to gain a foothold in a crowded market.
7754
GlaxoSmithKline files for European approval of diabetes drug albiglutide
27122
Verona Pharma plc - Issue of equity to raise approximately GBP3 million
67280
Food group Agrokor issues EUR 400mn Eurobonds.
147065
Glaxosmithkline not to pursue further worldwide development of Simplirix
89421
European Medicines Agency recommends restricting use of Pandemrix
98665
Chemicals in cherries could help combat diabetes
25337
Boehringer Ingelheim's Pradaxa approved in Canada
143760
GlaxoSmithKline to cut 130 jobs (gsk)
66069
Targacept publicly offering 2.2 million shares
118459
GlaxoSmithKline to create up to 1,000 jobs
134016
European medicines Agency recommends suspension of Avandia, Avandamet and Avaglim
112374
AdnaGen enters into agreement to license antibodies to KellBenx
110579
Scientists harness new drug discovery tool to treat diabetes
133645
Wockhardt received tentative approval for the Fexofenadine Hydrochloride
97157
Pharmaceutical firms lead FTSE 100 higher
87231
Alexion plans to launch eculizumab in Japan
175139
Glenmark planning to submit new drug application